Mutations in these genes, or in COL17A1, disrupt epithelial cell anchorage and cause junctional epidermolysis bullosa (EB), a genetic disorder where patients suffer from extremely fragile surface ...

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...

From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.

June 13, 2025 — Teens might finally have a good reason to sleep in on weekends within limits. A new study reveals that teenagers who get up to two extra hours of sleep on weekends show fewer ...

DEB is one of the more severe forms of the epidermolysis bullosa (EB) group – sometimes referred to as "the worst disease you have never heard of" – which is characterised by fragile skin that ...

The FDA has approved Krystal Biotech’s gene therapy Vyjuvek for dystrophic epidermolysis bullosa (DEB), a rare genetic disease characterised by fragile skin that can split and blister even with ...

The UAB Department of Family and Community Medicine is nationally known for our compassionate care, cutting-edge research, and comprehensive training programs, we're dedicated to delivering the most ...

Epidermolysis bullosa (EB) is a heterogeneous group of rare genetic ... the level of blistering within the dermal-epidermal junction, namely, EB simplex (EBX), junctional EB (JEB) and dystrophic EB ...

The AHA/ACC Joint Committee on Clinical Practice Guidelines (Joint Committee) continuously reviews, updates, and modifies guideline methodology on the basis of published standards from organizations, ...

Women in Medicine Summit View Oct. 15 - Oct. 18 American Shoulder and Elbow Surgeons Annual Meeting View Podcasts View more Primary Care June 18, 2025 47 min listen ...

Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around ...